2、 Crhr2 senior pharmacist and its use

摘要

The invention refers to new peptides, which are selective agonists of type 2 corticosteroid releasing hormone receptor and components of type 2 corticosteroid used for treating, improving or inhibiting cardiovascular conditions, including but not limited to heart failure. New anesthetics should preferably include modifications including viscous peptides. On the other hand, the present invention also relates to methods for the treatment and prevention of diseases or disorders related to crhr2 activities.